期刊文献+

拉西地平治疗糖尿病并发高血压及单纯高血压的疗效 被引量:6

Lacidipine in treating hypertensive patients with and without diabetes mellitus
下载PDF
导出
摘要 目的:观察拉西地平对糖尿病并发高血压和单纯高血压的治疗效果。方法:单纯高血压和糖尿病并发高血压各25例,服安慰剂 2 wk后服用拉西地平2 mg,如血压未降至正常,则渐增到4,6 mg或 8 mg,po, qm, pc,共 6 wk。结果: 2组治疗 2wk后收缩压分别下降达(3.4±0.6)kPa或(3.5±0.6)kPa,(P<0.01);舒张压分别下降达(2.0±0. 3) kPa或(2. 2± 0. 4) kPa( P< 0. 05)。治疗 4 wk及6wk,均显示收缩压进一步下降;舒张压均维持原疗效;治疗6wk期间对心率、血糖、血脂均无显著影响。结论:拉西地平治疗单纯性或糖尿病并发高血压均有较好疗效。 AIM: AIM: To study lacidipine treatment on diabetic and nondiabetic hypertensive patients. METHODS: Hypertensive patients with (n = 25) and without (n = 25 ) non-insulin- depen-dent diabetes mullitus were given placebo for 2 wk and then lacidipine 2 mg, po, after breakfast for 6 wk. The dosage was increased to 4, 6, or 8 mg if blood pressure was not controlled in normal range. RESULTS: The present study indicates that lacidipine significantly reduced blood pressure after 2 wk (P <0. 01, or P<0. 05) as the treatment time goes on (at 4 wk, 6 wk), the SBP was further depressed, and the DBP effect can be maintained. Lacidipine can' t interference of blood lipid and blood glucose. CONCLUSION: Lacidipine is a' good antihypertensive drug in hypertensive patients with and without NIDDM.
机构地区 中国人民解放军
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2000年第2期121-123,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 拉西地平 高血压 糖尿病 并发症 药物疗法 lacidipine hypertension non- in-sulin-dependent diabetes mellitus calcium channel blockers
  • 相关文献

参考文献8

  • 1Leren P,Helgeland A,Holme I,et al.Effect of propranolol and prazosin on blood lipids. The Oslo Study[].LancetThe.1980
  • 2Joint National Committee.The fifth report of the joint national committee on detection, evaluation and treatment of high blood pressure[].Archives of Internal Medicine.1993
  • 3Micheli D,Collodel A,Semeraro C,GaViraghi G,Carpi C.Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies[].Journal of Cardiovascular Pharmacology.1990
  • 4Godfraind T,Salomone S.Functional interaction of lacidipine withcalcium channels in vascular smooth muscle[].Journal of Cardiovascular Pharmacology.
  • 5Leonetti G,Salvi S.A long-term study comparing lacidipine andnifedipine SR in hypertensive patients: safety data[].Journal of Cardiovascular Pharmacology.
  • 6Lombardo D,Raimondi F.Efficacy and safety evaluation of lacidipine compared with amlodipine in mild-to-moderate hypertensive patients[].Journal of Cardiovascular Pharmacology.
  • 7Morris AD,Donnelly R,Connell JMC,Reid JL.Metabolic effectsof lacidipine: a placebo-controlled study using the euglycaemic hyperinsulinaemic clamp[].British Journal of Clinical Pharmacology.1993
  • 8Gulizia M,Valenti R,Platania F,D’Onofrio V,Rizzini P,CircoA.Calcium antagonist antihypertensive treatment of non-insulin-dependent diabetics: efficacy and safety of lacidipine versus nifedipine SR[].Journal of Cardiovascular Pharmacology.

同被引文献26

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2林金秀,陈达光,黄端,郑舒亮.氨氯地平对高血压病人胰岛素敏感性的影响[J].中华心血管病杂志,1996,24(2):97-100. 被引量:26
  • 3孙宁玲,杨宗于,苟淑琴,张向阳,李彤妹,祁瑞环.高血压合并高脂血症患者胰岛素抵抗与血浆内皮素、心钠素的观察[J].中华心血管病杂志,1996,24(3):210-213. 被引量:17
  • 4Zanchetti A,Bond MG,Henning M,et al.Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis:principal results of European lacidipine study on atheroscleresis(ELSA),a randomized,double-blind,long-term trial[J].Circulation,2002,106(19):C2422-C2424.
  • 5Pedroncelli A.A new calcium antagonist lacidipine in the throne treatment of diberic hypertensive panents (Abstract)[R].Fifth Interntional Mceting on Drabetes.Milan,March,1991.
  • 6Skislocki ALM,Hoffman BB,Reaven GM.Insulin resistance, glucose tolerance an d hyperinsulinemia in patients with hypertension[J].Am J Hypertens,1989,2:419-4 23.
  • 7Lee CR,Bryson HM.Lacidipine:A review of its pharmacodynamic and pharmacokin etic properties and therapeutic potential in the treatment of hypertension[J]. Drug,1994,48:274-296.
  • 8Lombardo D,Raimondi F.Efficacy and safety evaluation of lacidipine compared with amlodipine in mild-to-moderate hypertensive patients[J].J Cardiovasc P harmacol,1994,23 Suppl 5:S98-S100.
  • 9Swislocki A.Insulin resistance and hypertension[J].Am J Med Sci,1990,300: 104-115.
  • 10Lefebrrel J ,Poirier L,Archambault F,et al .Comparative effects of felodipine ER,amlodipine and nifedipine GITS on 24h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension a forced titration study[J] .Can J Cardiol,1998,14:682.

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部